CA2347656A1 - Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons - Google Patents

Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons Download PDF

Info

Publication number
CA2347656A1
CA2347656A1 CA002347656A CA2347656A CA2347656A1 CA 2347656 A1 CA2347656 A1 CA 2347656A1 CA 002347656 A CA002347656 A CA 002347656A CA 2347656 A CA2347656 A CA 2347656A CA 2347656 A1 CA2347656 A1 CA 2347656A1
Authority
CA
Canada
Prior art keywords
levels
cancer
patient
lsgdp
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002347656A
Other languages
English (en)
Inventor
Fei Yang
Yongming Sun
Herve Recipon
Roberto A. Macina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2347656A1 publication Critical patent/CA2347656A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention se rapporte à de nouveaux procédés servant à la détection, au diagnostic, à la surveillance, à la classification par stades, au pronostic, à l'imagerie et au traitement du cancer des poumons.
CA002347656A 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons Abandoned CA2347656A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9523398P 1998-08-04 1998-08-04
US60/095,233 1998-08-04
PCT/US1999/016247 WO2000008206A1 (fr) 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons

Publications (1)

Publication Number Publication Date
CA2347656A1 true CA2347656A1 (fr) 2000-02-17

Family

ID=22250833

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347656A Abandoned CA2347656A1 (fr) 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons

Country Status (4)

Country Link
EP (1) EP1104486A4 (fr)
JP (1) JP3524061B2 (fr)
CA (1) CA2347656A1 (fr)
WO (1) WO2000008206A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869592B1 (en) 1998-08-04 2005-03-22 Diadexus, Inc. Method and antibody for imaging lung cancer
AU2001286810A1 (en) * 2000-08-28 2002-03-13 Diadexus, Inc. Compositions and methods relating to lung specific genes
JP2004520821A (ja) * 2000-10-26 2004-07-15 ディアデクサス インコーポレーテッド 肺特異的遺伝子およびタンパク質に関する組成物および方法
AU2002220009A1 (en) * 2000-11-20 2002-05-27 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
WO2002064788A2 (fr) * 2000-11-20 2002-08-22 Diadexus, Inc. Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons
WO2002068633A2 (fr) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions et procedes concernant des genes et proteines specifiques aux poumons
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
MX369276B (es) 2012-11-13 2019-11-04 Biontech Ag Agentes para tratamiento de enfermedades cancerosas que expresan claudina.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0695760A1 (fr) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Marqueur tumorale pour détecter le cancer du poumon
WO1998020143A1 (fr) * 1996-11-05 1998-05-14 Abbott Laboratories Reactifs et procedes pour le depistage de maladies pulmonaires
JP2001526546A (ja) * 1997-06-11 2001-12-18 アボツト・ラボラトリーズ 肺の疾患の検出に有用な試薬および方法
JP3688585B2 (ja) * 1998-05-21 2005-08-31 ダイアデクスアス・インコーポレーテッド 肺癌を診断し、モニターし、そして病期決定する新規方法

Also Published As

Publication number Publication date
JP2002522046A (ja) 2002-07-23
JP3524061B2 (ja) 2004-04-26
EP1104486A4 (fr) 2002-07-17
EP1104486A1 (fr) 2001-06-06
WO2000008206A1 (fr) 2000-02-17

Similar Documents

Publication Publication Date Title
US7858325B2 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US8029787B2 (en) Method of diagnosing, monitoring, staging, imaging and treating various cancers
US6902892B1 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000008210A1 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
US20050266483A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1131095A1 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
CA2347656A1 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
EP1117833A1 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
EP1126877A1 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
US6869592B1 (en) Method and antibody for imaging lung cancer
US6962779B1 (en) Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US7326402B2 (en) Method of diagnosing, monitoring, staging, imaging and treating cancer
US6737040B1 (en) Method and antibody for imaging breast cancer
CA2346326A1 (fr) Nouveau procede de diagnostic, de controle, de stadification, d'imagerie et de traitement de cancers gynecologiques ou de cancers de la prostate
WO2000012761A1 (fr) Nouvel anticorps permettant de diagnostiquer le cancer de la vessie
CA2394914A1 (fr) Nouvelle methode de diagnostic, de suivi, de stadification, d'imagerie et de traitement du cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued